You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Details for New Drug Application (NDA): 018705

✉ Email this page to a colleague

« Back to Dashboard

NDA 018705 describes NITROLINGUAL PUMPSPRAY, which is a drug marketed by Pohl Boskamp and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug and two Paragraph IV challenges. Additional details are available on the NITROLINGUAL PUMPSPRAY profile page.

The generic ingredient in NITROLINGUAL PUMPSPRAY is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the nitroglycerin profile page.

Summary for 018705

Tradename:	NITROLINGUAL PUMPSPRAY
Applicant:	Pohl Boskamp
Ingredient:	nitroglycerin
Patents:	1
Formulation / Manufacturing:	see details

Pharmacology for NDA: 018705

Physiological Effect	Vasodilation

Medical Subject Heading (MeSH) Categories for 018705

Explosive Agents
Vasodilator Agents

Suppliers and Packaging for NDA: 018705

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
NITROLINGUAL	nitroglycerin	AEROSOL;SUBLINGUAL	018705	NDA AUTHORIZED GENERIC	Allegis Pharmaceuticals, LLC	28595-120	28595-120-12	1 BOTTLE in 1 CARTON (28595-120-12) / 200 SPRAY in 1 BOTTLE
NITROLINGUAL	nitroglycerin	AEROSOL;SUBLINGUAL	018705	NDA AUTHORIZED GENERIC	Allegis Pharmaceuticals, LLC	28595-120	28595-120-49	1 BOTTLE in 1 CARTON (28595-120-49) / 60 SPRAY in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	AEROSOL;SUBLINGUAL			Strength	0.4MG/SPRAY
Approval Date:	Oct 31, 1985	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	SPRAY, METERED;SUBLINGUAL			Strength	0.4MG/SPRAY
Approval Date:	Jan 10, 1997	TE:	AB	RLD:	Yes
Patent:	⤷ Try a Trial	Patent Expiration:	Mar 12, 2029	Product Flag?	Y	Substance Flag?		Delist Request?
Patented Use:	METHOD OF TREATING ANGINA PECTORIS

Expired US Patents for NDA 018705

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pohl Boskamp	NITROLINGUAL PUMPSPRAY	nitroglycerin	SPRAY, METERED;SUBLINGUAL	018705-002	Jan 10, 1997	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.